肝胆膵外科学分野

24  件  
※ 登録方法の違いにより重複して表示されている場合があります。

  1. Yohei Tabe, Eito Nakagawa, Daisuke Asano, Eriko Katsuta, Daisuke Ban, Shogo Kumagai: Genomic Evolution and Immune Contexture With Therapeutic Relevance in Pancreatic Neuroendocrine Neoplasms. Cancer Sci. 2026.07; Online ahead of print. ( PubMed , DOI )

  2. Atsushi Nara, Shu Shimada, Yoshimitsu Akiyama, Megumi Hatano, Yusuke Chino, Suguru Miyazawa, Hanako Tamura, Daisuke Asano, Yoshiya Ishikawa, Hiroki Ueda, Shuichi Watanabe, Eriko Katsuta, Keiichi Akahoshi, Kenichi Ohashi, Minoru Tanabe, Daisuke Ban, Shinji Tanaka: Targeting SPP1-CD44-Hedgehog Axis Elicits Therapeutic Effects in Hepatocellular Carcinoma by Suppressing Intratumoral Fibrosis. Cancer Sci. 2026.03; 117 (3): 670-682. ( PubMed , DOI )

  3. Atsushi Nara, Hiroki Ueda, Yukue Shimizu, Daisuke Asano, Yoshiya Ishikawa, Keiichi Akahoshi, Eriko Katsuta, Junko Torigoe, Daisuke Ban: Minimally invasive surgery reduces the risk of loss of independence after pancreatoduodenectomy in elderly patients. Surg Endosc. 2026.03; 40 (3): 2332-2340. ( PubMed , DOI )

  4. Hiromune Katsuda, Go Ito, Franziska Kimmig, Tomohiro Muto, Neha Mishra, Joana Pimenta Bernardes, Yui Hiraguri, Hironari Yamashita, Akira Ito, Yuko Kinowaki, Takahiro Shin, Satoru Fujii, Masato Miyoshi, Masanori Kobayashi, Daisuke Asano, Yoshiya Ishikawa, Hiroki Ueda, Keiichi Akahoshi, Eriko Katsuta, Yoshihito Kano, Shiro Yui, Yasuhiro Nemoto, Atsushi Kudo, Daisuke Ban, Yasuhiro Asahina, Stefan Schreiber, Mamoru Watanabe, Philip Rosenstiel, Ryuichi Okamoto: DOCK10 Regulates Insulin Hypersecretion in Insulinoma and Serves as a Diagnostic and Therapeutic Target. Cell Mol Gastroenterol Hepatol. 2026; 20 (5): 101705. ( PubMed , DOI )

  1. Hirofumi Yamada, Kota Yokoyama, Junichi Tsuchiya, Miki Miura, Eriko Katsuta, Keiichi Akahoshi, Tomomi Akiyama, Keisuke Takino, Daisuke Ban, Ukihide Tateishi: Lu-DOTATATE therapy: A clinically manageable phenomenon with increased risk in patients with cardiac enlargement. Ann Nucl Med. 2025.12; Online ahead of print. ( PubMed , DOI )

  2. Shohei Motohashi, Eriko Katsuta, Daisuke Ban: Advances and Challenges in Drug Screening for Cancer Therapy: A Comprehensive Review. Bioengineering (Basel). 2025.12; 12 (12): 1315. ( PubMed , DOI )

  3. Joshua Rivera, Qi Yan, Saeed Daneshmandi, Romain Lannes, Eriko Katsuta, JeeEun Choi, Prashant Singh, Ahmed Belal, Ronald Alberico, Ian Lund, Megan Schaefer, Hamza Hassan, Sarah Parker, Kenneth C Anderson, Nikhil C Munshi, Mehmet Samur, Philip L McCarthy, Jens Hillengass, Hemn Mohammadpour: Deciphering neutrophil dynamics in the focal lesion tumor microenvironment to overcome immunosuppression in multiple myeloma. Blood. 2025.11; 146 (20): 2392-2405. ( PubMed , DOI )

  4. Yohei Tabe, Hiroaki Ono, Satoshi Matsui, Daisuke Asano, Yoshiya Ishikawa, Hiroki Ueda, Keiichi Akahoshi, Eriko Katsuta, Daisuke Ban: Comparative analysis of streptozocin-based regimen and capecitabine-temozolomide therapy in advanced pancreatic neuroendocrine neoplasms: influence of tumor grade and Ki-67 index. Ther Adv Med Oncol. 2025.11; 17 17588359251389742. ( PubMed , DOI )

  5. Noritoshi Kobayashi, Yasuhiro Yabushita, Ryutaro Mori, Tomoaki Takahashi, Kentaro Miyake, Yu Sawada, Yuki Homma, Ryusei Matsuyama, Naoki Okubo, Eriko Katsuta, Kensuke Kubota, Shoji Yamanaka, Yasushi Ichikawa, Itaru Endo: Treatment of initially unresectable local advanced pancreatic adenocarcinoma with FOLFIRINOX: A prospective study YCOG1403 (C-FLAP study). Sci Rep. 2025.11; 15 (1): 39884. ( PubMed , DOI )

  6. Yohei Tabe, Daisuke Asano, Hayato Takamizawa, Satoshi Matsui, Yoshiya Ishikawa, Hiroki Ueda, Keiichi Akahoshi, Eriko Katsuta, Yuki Kato, Yuko Kinowaki, Daisuke Ban: Late-Onset Para-Aortic Lymph Node Recurrence 11 Years after Resection of Pancreatic Cancer: Histological Reassessment Revealed Neuroendocrine Differentiation Amenable to Surgical Resection. Surg Case Rep. 2025.09; 11 (1): 25-0374. ( PubMed , DOI , 医中誌 )

  7. Suguru Miyazawa, Hiroaki Ono, Hironari Yamashita, Daisuke Asano, Yoshiya Ishikawa, Shuichi Watanabe, Hiroki Ueda, Satoru Aoyama, Naoya Ishibashi, Keiichi Akahoshi, Sadakatsu Ikeda, Minoru Tanabe: Evaluation of therapeutic agent selection based on comprehensive genomic profiling in gastroenteropancreatic neuroendocrine neoplasms. PLoS One. 2025.08; 20 (8): e0325727. ( PubMed , DOI )

  8. Shin-La Shu, Shawna Benjamin-Davalos, Xue Wang, Eriko Katsuta, Megan Fitzgerald, Marina Koroleva, Cheryl L Allen, Flora Qu, Gyorgy Paragh, Hans Minderman, Pawel Kalinski, Kazuaki Takabe, Marc S Ernstoff: Scaffold-Free Functional Deconvolution Identifies Clinically Relevant Metastatic Melanoma EV Biomarkers. Cancers (Basel). 2025.07; 17 (15): 2509. ( PubMed , DOI )

  9. Shohei Motohashi, Daisuke Asano, Satoshi Matsui, Yoshiya Ishikawa, Hiroki Ueda, Keiichi Akahoshi, Eriko Katsuta, Daisuke Ban: A Case of Curative Resection by Minimally Invasive Surgery in Two Stages Using the Hormonal Mapping Test for Pancreatic Head ACTHoma with Multiple Liver Metastases. Surg Case Rep. 2025; 11 (1): 25-0542. ( PubMed , DOI )

  1. Atsushi Oba, Atsushi Kudo, Keiichi Akahoshi, Mitsuhiro Kishino, Takumi Akashi, Eriko Katsuta, Yasuhito Iwao, Hiroaki Ono, Yusuke Mitsunori, Daisuke Ban, Shinji Tanaka, Yoshinobu Eishi, Ukihide Tateishi, Minoru Tanabe: A simple morphological classification to estimate the malignant potential of pancreatic neuroendocrine tumors. J. Gastroenterol.. 2017.05; 52 (10): 1140-1146. ( PubMed , DOI )

  1. Eriko Katsuta, Atsushi Kudo, Takumi Akashi, Yusuke Mitsunori, Satoshi Matsumura, Arihiro Aihara, Daisuke Ban, Takanori Ochiai, Shinji Tanaka, Yoshinobu Eishi, Minoru Tanabe: Macroscopic morphology for estimation of malignant potential in pancreatic neuroendocrine neoplasm J Cancer Res Clin Oncol . 2016.06; 142 1299-1306.

  2. Katsuta E, Tanaka S, Mogushi K, Shimada S, Akiyama Y, Aihara A, Matsumura S, Mitsunori Y, Ban D, Ochiai T, Kudo A, Fukamachi H, Tanaka H, Nakayama K, Arii S, Tanabe M.: CD73 as a therapeutic target for pancreatic neuroendocrine tumor stem cells. Int J Oncol. . 2016.02; 48 (2): 657-669.

  1. Katsuta E, Tanaka S, Mogushi K, Matsumura S, Ban D, Ochiai T, Irie T, Kudo A, Nakamura N, Tanaka H, Tanabe M, Arii S.: Age-related clinicopathologic and molecular features of patients receiving curative hepatectomy for hepatocellular carcinoma. Am. J. Surg.. 2014.09; 208 (3): 450-456. ( PubMed , DOI )

  1. 石川 喜也, 浅野 大輔, 上田 浩樹, 赤星 径一, 勝田 絵里子, 伴 大輔: 【消化器・一般外科における技術認定制度を意識した内視鏡外科手術教育と手技の工夫】外科解剖　腹腔鏡下尾側膵切除術(脾温存/脾合併切除)に必要な外科解剖 手術. 2026.04; 80 (5): 721-728.

  2. 石川 喜也, 浅野 大輔, 上田 浩樹, 古山 貴基, 勝田 絵里子, 赤星 径一, 伴 大輔: 【新・膜と層を意識した消化器外科解剖　肝胆膵編】膵頭部の解剖 消化器外科. 2026.04; 49 (4): 389-400.

  3. 石川 喜也, 浅野 大輔, 上田 浩樹, 赤星 径一, 勝田 絵里子, 伴 大輔: 【肝胆膵外科解剖を再考する-Precision anatomy for minimally invasive HBP surgery】膵頭十二指腸切除に必要な上腸間膜動脈・門脈周囲の微細解剖 手術. 2026.01; 80 (1): 67-74.

  1. 松井 聡, 浅野 大輔, 石川 喜也, 上田 浩樹, 赤星 径一, 勝田 絵里子, 伴 大輔: 【周術期管理マニュアル-保存版】術式別の術前・術中・術後管理 【肝】通常肝切除. 臨床外科. 2025.10; 80 (11): 169-172.

  2. 浅野 大輔, 松井 聡, 石川 喜也, 上田 浩樹, 勝田 絵里子, 赤星 径一, 伴 大輔: 【肝胆膵の手術を支えるチーム医療-合併症対策-】肝臓　胸水・腹水への適切な対応 ドレナージ,利尿剤,適切なアルブミン投与など. 肝胆膵. 2025.10; 91 (4): 469-471. ( 医中誌 )

  1. 伊藤 晃、伴 大輔、水井 崇浩、宮田 明典、奈良 聡、江崎 稔: 低侵襲膵切除に重要な局所解剖. 外科. 2024.11; 86 (12): 1305-1310.

  1. 伊藤　晃、上田浩樹、浅野大輔、石川喜也、渡邊秀一、赤星径一、小野宏晃、田邉　稔: 胆石症の分類と各種治療法 臨床外科増刊号. 2023.10; 78 (11): 230-235.

このページの先頭へ▲